Considering the important roles of HGF-MET signaling in invasive growth, drug resistance and maintaining the stem cell phenotype of tumor cells, targeting proHGF activation may provide additional options to overcome the malignant phenotypes of tumor cells. Here, HGF is linked to neoplasm.